Metreleptin for treating lipodystrophy (HST14)
Evidence-based recommendations on metreleptin (Myalepta) for treating lipodystrophy in children and adults
Search results
1 result
Sorted by Date . | Sort by Relevance
- Guidance Remove Guidance filter
- NICE Pathways Remove NICE Pathways filter
- Published Remove Published filter
- Last 3 months Remove Last 3 months filter
- Highly specialised technologies guidance Remove Highly specialised technologies guidance filter
- Safe staffing guidelines Remove Safe staffing guidelines filter
- Public health guidelines Remove Public health guidelines filter
- COVID-19 NHSE/I specialty guides Remove COVID-19 NHSE/I specialty guides filter